These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

169 related articles for article (PubMed ID: 24521489)

  • 1. Investigating hapten clustering as a strategy to enhance vaccines against drugs of abuse.
    Collins KC; Janda KD
    Bioconjug Chem; 2014 Mar; 25(3):593-600. PubMed ID: 24521489
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Hapten-specific naïve B cells are biomarkers of vaccine efficacy against drugs of abuse.
    Taylor JJ; Laudenbach M; Tucker AM; Jenkins MK; Pravetoni M
    J Immunol Methods; 2014 Mar; 405():74-86. PubMed ID: 24462800
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Selection of a novel anti-nicotine vaccine: influence of antigen design on antibody function in mice.
    Pryde DC; Jones LH; Gervais DP; Stead DR; Blakemore DC; Selby MD; Brown AD; Coe JW; Badland M; Beal DM; Glen R; Wharton Y; Miller GJ; White P; Zhang N; Benoit M; Robertson K; Merson JR; Davis HL; McCluskie MJ
    PLoS One; 2013; 8(10):e76557. PubMed ID: 24098532
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Characterization and optimization of heroin hapten-BSA conjugates: method development for the synthesis of reproducible hapten-based vaccines.
    Torres OB; Jalah R; Rice KC; Li F; Antoline JF; Iyer MR; Jacobson AE; Boutaghou MN; Alving CR; Matyas GR
    Anal Bioanal Chem; 2014 Sep; 406(24):5927-37. PubMed ID: 25084736
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A new strategy for improved nicotine vaccines using conformationally constrained haptens.
    Meijler MM; Matsushita M; Altobell LJ; Wirsching P; Janda KD
    J Am Chem Soc; 2003 Jun; 125(24):7164-5. PubMed ID: 12797775
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Engineering of a hybrid nanoparticle-based nicotine nanovaccine as a next-generation immunotherapeutic strategy against nicotine addiction: A focus on hapten density.
    Zhao Z; Powers K; Hu Y; Raleigh M; Pentel P; Zhang C
    Biomaterials; 2017 Apr; 123():107-117. PubMed ID: 28167389
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Enhancement of a Heroin Vaccine through Hapten Deuteration.
    Belz TF; Bremer PT; Zhou B; Ellis B; Eubanks LM; Janda KD
    J Am Chem Soc; 2020 Aug; 142(31):13294-13298. PubMed ID: 32700530
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Synthesis and immunological effects of heroin vaccines.
    Li F; Cheng K; Antoline JF; Iyer MR; Matyas GR; Torres OB; Jalah R; Beck Z; Alving CR; Parrish DA; Deschamps JR; Jacobson AE; Rice KC
    Org Biomol Chem; 2014 Oct; 12(37):7211-32. PubMed ID: 24995943
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Efficacy, but not antibody titer or affinity, of a heroin hapten conjugate vaccine correlates with increasing hapten densities on tetanus toxoid, but not on CRM197 carriers.
    Jalah R; Torres OB; Mayorov AV; Li F; Antoline JF; Jacobson AE; Rice KC; Deschamps JR; Beck Z; Alving CR; Matyas GR
    Bioconjug Chem; 2015 Jun; 26(6):1041-53. PubMed ID: 25970207
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Probing the effects of hapten stability on cocaine vaccine immunogenicity.
    Cai X; Whitfield T; Moreno AY; Grant Y; Hixon MS; Koob GF; Janda KD
    Mol Pharm; 2013 Nov; 10(11):4176-84. PubMed ID: 23927436
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Prescreening of Nicotine Hapten Linkers in Vitro To Select Hapten-Conjugate Vaccine Candidates for Pharmacokinetic Evaluation in Vivo.
    Arutla V; Leal J; Liu X; Sokalingam S; Raleigh M; Adaralegbe A; Liu L; Pentel PR; Hecht SM; Chang Y
    ACS Comb Sci; 2017 May; 19(5):286-298. PubMed ID: 28383252
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A simple nonradioactive method for the determination of the binding affinities of antibodies induced by hapten bioconjugates for drugs of abuse.
    Torres OB; Antoline JF; Li F; Jalah R; Jacobson AE; Rice KC; Alving CR; Matyas GR
    Anal Bioanal Chem; 2016 Feb; 408(4):1191-204. PubMed ID: 26677020
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The frequency of early-activated hapten-specific B cell subsets predicts the efficacy of vaccines for nicotine dependence.
    Laudenbach M; Tucker AM; Runyon SP; Carroll FI; Pravetoni M
    Vaccine; 2015 Nov; 33(46):6332-9. PubMed ID: 26409811
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Influence of Small Molecular Property on Antibody Response.
    Wen K; Bai Y; Wei Y; Li C; Shen J; Wang Z
    J Agric Food Chem; 2020 Sep; 68(39):10944-10950. PubMed ID: 32854496
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Modulating cocaine vaccine potency through hapten fluorination.
    Cai X; Tsuchikama K; Janda KD
    J Am Chem Soc; 2013 Feb; 135(8):2971-4. PubMed ID: 23398531
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Consequence of Hapten Stereochemistry: An Efficacious Methamphetamine Vaccine.
    Olson ME; Sugane T; Zhou B; Janda KD
    J Am Chem Soc; 2019 Sep; 141(36):14089-14092. PubMed ID: 31479256
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Molecular attributes of conjugate antigen influence function of antibodies induced by anti-nicotine vaccine in mice and non-human primates.
    McCluskie MJ; Thorn J; Mehelic PR; Kolhe P; Bhattacharya K; Finneman JI; Stead DR; Piatchek MB; Zhang N; Chikh G; Cartier J; Evans DM; Merson JR; Davis HL
    Int Immunopharmacol; 2015 Apr; 25(2):518-27. PubMed ID: 25737198
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Synthesis of mercapto-(+)-methamphetamine haptens and their use for obtaining improved epitope density on (+)-methamphetamine conjugate vaccines.
    Carroll FI; Blough BE; Pidaparthi RR; Abraham P; Gong PK; Deng L; Huang X; Gunnell M; Lay JO; Peterson EC; Owens SM
    J Med Chem; 2011 Jul; 54(14):5221-8. PubMed ID: 21682289
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Impact of distinct chemical structures for the development of a methamphetamine vaccine.
    Moreno AY; Mayorov AV; Janda KD
    J Am Chem Soc; 2011 May; 133(17):6587-95. PubMed ID: 21473576
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Hapten optimization for cocaine vaccine with improved cocaine recognition.
    Ramakrishnan M; Kinsey BM; Singh RA; Kosten TR; Orson FM
    Chem Biol Drug Des; 2014 Sep; 84(3):354-63. PubMed ID: 24803171
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.